Compare Cart
  • Japanese
Cover Image
Market Research Report
Product code 
1052454

Global Biologic Injectors Market Insights and Forecast to 2028
Published: | QYResearch | 91 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Biologic Injectors Market Insights and Forecast to 2028
Published: January 20, 2022
QYResearch
Content info: 91 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Biologic injectors are the injecting devices used to deliver drugs and other substances for biological purposes. Biological products such as drugs, growth hormones, antibodies and other complex biological molecules are administered into the body of an organism through biologic injectors. Biologic injectors are basically used for the treatment of various diseases.

Market Analysis and Insights: Global Biologic Injectors Market

Due to the COVID-19 pandemic, the global Biologic Injectors market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Disposable Biologic Injectors accounting for % of the Biologic Injectors global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.

Biologic injectors offer different methods of administration such as simple piston, gas, jet and others. They can also be used for the storage or handling of biological molecules. Accurate dosing is one the most important advantages offered by biologic injectors. Thus, the risk of overdose of a drug is significantly reduced with the use of biologic injectors, which is considered as a major advantage of biologics injectors. Biologic injectors can be used for the delivery of general drug or any drug of a specific product line. They can be used for the administration of single doses or multiple doses and the dosage of the drug can be adjusted by the user.

Global Biologic Injectors Scope and Segment

Biologic Injectors market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Biologic Injectors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Disposable Biologic Injectors
  • Reusable Biologic Injectors

Segment by Application

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

By Company

  • BD
  • Johnson & Johnson
  • Roche
  • Schott
  • Bayer
  • Nipro
  • Ompi
  • Novartis

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Biologic Injectors Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Biologic Injectors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Disposable Biologic Injectors
    • 1.2.3 Reusable Biologic Injectors
  • 1.3 Market by Application
    • 1.3.1 Global Biologic Injectors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Ambulatory Surgical Centers
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Biologic Injectors Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Biologic Injectors Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Biologic Injectors Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Biologic Injectors Sales by Region
    • 2.4.1 Global Biologic Injectors Sales by Region (2017-2022)
    • 2.4.2 Global Sales Biologic Injectors by Region (2023-2028)
  • 2.5 Global Biologic Injectors Revenue by Region
    • 2.5.1 Global Biologic Injectors Revenue by Region (2017-2022)
    • 2.5.2 Global Biologic Injectors Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Biologic Injectors Sales by Manufacturers
    • 3.1.1 Global Top Biologic Injectors Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Biologic Injectors Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biologic Injectors in 2021
  • 3.2 Global Biologic Injectors Revenue by Manufacturers
    • 3.2.1 Global Biologic Injectors Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Biologic Injectors Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Biologic Injectors Revenue in 2021
  • 3.3 Global Biologic Injectors Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Biologic Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Biologic Injectors Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Biologic Injectors Sales by Type
    • 4.1.1 Global Biologic Injectors Historical Sales by Type (2017-2022)
    • 4.1.2 Global Biologic Injectors Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Biologic Injectors Sales Market Share by Type (2017-2028)
  • 4.2 Global Biologic Injectors Revenue by Type
    • 4.2.1 Global Biologic Injectors Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Biologic Injectors Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Biologic Injectors Revenue Market Share by Type (2017-2028)
  • 4.3 Global Biologic Injectors Price by Type
    • 4.3.1 Global Biologic Injectors Price by Type (2017-2022)
    • 4.3.2 Global Biologic Injectors Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Biologic Injectors Sales by Application
    • 5.1.1 Global Biologic Injectors Historical Sales by Application (2017-2022)
    • 5.1.2 Global Biologic Injectors Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Biologic Injectors Sales Market Share by Application (2017-2028)
  • 5.2 Global Biologic Injectors Revenue by Application
    • 5.2.1 Global Biologic Injectors Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Biologic Injectors Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Biologic Injectors Revenue Market Share by Application (2017-2028)
  • 5.3 Global Biologic Injectors Price by Application
    • 5.3.1 Global Biologic Injectors Price by Application (2017-2022)
    • 5.3.2 Global Biologic Injectors Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Biologic Injectors Market Size by Type
    • 6.1.1 North America Biologic Injectors Sales by Type (2017-2028)
    • 6.1.2 North America Biologic Injectors Revenue by Type (2017-2028)
  • 6.2 North America Biologic Injectors Market Size by Application
    • 6.2.1 North America Biologic Injectors Sales by Application (2017-2028)
    • 6.2.2 North America Biologic Injectors Revenue by Application (2017-2028)
  • 6.3 North America Biologic Injectors Market Size by Country
    • 6.3.1 North America Biologic Injectors Sales by Country (2017-2028)
    • 6.3.2 North America Biologic Injectors Revenue by Country (2017-2028)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Biologic Injectors Market Size by Type
    • 7.1.1 Europe Biologic Injectors Sales by Type (2017-2028)
    • 7.1.2 Europe Biologic Injectors Revenue by Type (2017-2028)
  • 7.2 Europe Biologic Injectors Market Size by Application
    • 7.2.1 Europe Biologic Injectors Sales by Application (2017-2028)
    • 7.2.2 Europe Biologic Injectors Revenue by Application (2017-2028)
  • 7.3 Europe Biologic Injectors Market Size by Country
    • 7.3.1 Europe Biologic Injectors Sales by Country (2017-2028)
    • 7.3.2 Europe Biologic Injectors Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Biologic Injectors Market Size by Type
    • 8.1.1 Asia Pacific Biologic Injectors Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Biologic Injectors Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Biologic Injectors Market Size by Application
    • 8.2.1 Asia Pacific Biologic Injectors Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Biologic Injectors Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Biologic Injectors Market Size by Region
    • 8.3.1 Asia Pacific Biologic Injectors Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Biologic Injectors Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Biologic Injectors Market Size by Type
    • 9.1.1 Latin America Biologic Injectors Sales by Type (2017-2028)
    • 9.1.2 Latin America Biologic Injectors Revenue by Type (2017-2028)
  • 9.2 Latin America Biologic Injectors Market Size by Application
    • 9.2.1 Latin America Biologic Injectors Sales by Application (2017-2028)
    • 9.2.2 Latin America Biologic Injectors Revenue by Application (2017-2028)
  • 9.3 Latin America Biologic Injectors Market Size by Country
    • 9.3.1 Latin America Biologic Injectors Sales by Country (2017-2028)
    • 9.3.2 Latin America Biologic Injectors Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Biologic Injectors Market Size by Type
    • 10.1.1 Middle East and Africa Biologic Injectors Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Biologic Injectors Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Biologic Injectors Market Size by Application
    • 10.2.1 Middle East and Africa Biologic Injectors Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Biologic Injectors Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Biologic Injectors Market Size by Country
    • 10.3.1 Middle East and Africa Biologic Injectors Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Biologic Injectors Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 BD
    • 11.1.1 BD Corporation Information
    • 11.1.2 BD Overview
    • 11.1.3 BD Biologic Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 BD Biologic Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 BD Recent Developments
  • 11.2 Johnson & Johnson
    • 11.2.1 Johnson & Johnson Corporation Information
    • 11.2.2 Johnson & Johnson Overview
    • 11.2.3 Johnson & Johnson Biologic Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 Johnson & Johnson Biologic Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Johnson & Johnson Recent Developments
  • 11.3 Roche
    • 11.3.1 Roche Corporation Information
    • 11.3.2 Roche Overview
    • 11.3.3 Roche Biologic Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 Roche Biologic Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Roche Recent Developments
  • 11.4 Schott
    • 11.4.1 Schott Corporation Information
    • 11.4.2 Schott Overview
    • 11.4.3 Schott Biologic Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 Schott Biologic Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Schott Recent Developments
  • 11.5 Bayer
    • 11.5.1 Bayer Corporation Information
    • 11.5.2 Bayer Overview
    • 11.5.3 Bayer Biologic Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 Bayer Biologic Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Bayer Recent Developments
  • 11.6 Nipro
    • 11.6.1 Nipro Corporation Information
    • 11.6.2 Nipro Overview
    • 11.6.3 Nipro Biologic Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 Nipro Biologic Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Nipro Recent Developments
  • 11.7 Ompi
    • 11.7.1 Ompi Corporation Information
    • 11.7.2 Ompi Overview
    • 11.7.3 Ompi Biologic Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 Ompi Biologic Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Ompi Recent Developments
  • 11.8 Novartis
    • 11.8.1 Novartis Corporation Information
    • 11.8.2 Novartis Overview
    • 11.8.3 Novartis Biologic Injectors Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 Novartis Biologic Injectors Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Novartis Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Biologic Injectors Industry Chain Analysis
  • 12.2 Biologic Injectors Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Biologic Injectors Production Mode & Process
  • 12.4 Biologic Injectors Sales and Marketing
    • 12.4.1 Biologic Injectors Sales Channels
    • 12.4.2 Biologic Injectors Distributors
  • 12.5 Biologic Injectors Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Biologic Injectors Industry Trends
  • 13.2 Biologic Injectors Market Drivers
  • 13.3 Biologic Injectors Market Challenges
  • 13.4 Biologic Injectors Market Restraints

14 Key Findings in The Global Biologic Injectors Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

LIST OF TABLES

List of Tables

  • Table 1. Global Biologic Injectors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Disposable Biologic Injectors
  • Table 3. Major Manufacturers of Reusable Biologic Injectors
  • Table 4. Global Biologic Injectors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 5. Global Biologic Injectors Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 6. Global Biologic Injectors Sales by Region (2017-2022) & (K Units)
  • Table 7. Global Biologic Injectors Sales Market Share by Region (2017-2022)
  • Table 8. Global Biologic Injectors Sales by Region (2023-2028) & (K Units)
  • Table 9. Global Biologic Injectors Sales Market Share by Region (2023-2028)
  • Table 10. Global Biologic Injectors Revenue by Region (2017-2022) & (US$ Million)
  • Table 11. Global Biologic Injectors Revenue Market Share by Region (2017-2022)
  • Table 12. Global Biologic Injectors Revenue by Region (2023-2028) & (US$ Million)
  • Table 13. Global Biologic Injectors Revenue Market Share by Region (2023-2028)
  • Table 14. Global Biologic Injectors Sales by Manufacturers (2017-2022) & (K Units)
  • Table 15. Global Biologic Injectors Sales Share by Manufacturers (2017-2022)
  • Table 16. Global Biologic Injectors Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 17. Global Biologic Injectors Revenue Share by Manufacturers (2017-2022)
  • Table 18. Biologic Injectors Price by Manufacturers (2017-2022) &(USD/Unit)
  • Table 19. Global Biologic Injectors Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 20. Global Biologic Injectors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Injectors as of 2021)
  • Table 21. Biologic Injectors Manufacturing Base Distribution and Headquarters
  • Table 22. Manufacturers Biologic Injectors Product Offered
  • Table 23. Date of Manufacturers Enter into Biologic Injectors Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Biologic Injectors Sales by Type (2017-2022) & (K Units)
  • Table 26. Global Biologic Injectors Sales by Type (2023-2028) & (K Units)
  • Table 27. Global Biologic Injectors Sales Share by Type (2017-2022)
  • Table 28. Global Biologic Injectors Sales Share by Type (2023-2028)
  • Table 29. Global Biologic Injectors Revenue by Type (2017-2022) & (US$ Million)
  • Table 30. Global Biologic Injectors Revenue by Type (2023-2028) & (US$ Million)
  • Table 31. Global Biologic Injectors Revenue Share by Type (2017-2022)
  • Table 32. Global Biologic Injectors Revenue Share by Type (2023-2028)
  • Table 33. Biologic Injectors Price by Type (2017-2022) & (USD/Unit)
  • Table 34. Global Biologic Injectors Price Forecast by Type (2023-2028) & (USD/Unit)
  • Table 35. Global Biologic Injectors Sales by Application (2017-2022) & (K Units)
  • Table 36. Global Biologic Injectors Sales by Application (2023-2028) & (K Units)
  • Table 37. Global Biologic Injectors Sales Share by Application (2017-2022)
  • Table 38. Global Biologic Injectors Sales Share by Application (2023-2028)
  • Table 39. Global Biologic Injectors Revenue by Application (2017-2022) & (US$ Million)
  • Table 40. Global Biologic Injectors Revenue by Application (2023-2028) & (US$ Million)
  • Table 41. Global Biologic Injectors Revenue Share by Application (2017-2022)
  • Table 42. Global Biologic Injectors Revenue Share by Application (2023-2028)
  • Table 43. Biologic Injectors Price by Application (2017-2022) & (USD/Unit)
  • Table 44. Global Biologic Injectors Price Forecast by Application (2023-2028) & (USD/Unit)
  • Table 45. North America Biologic Injectors Sales by Type (2017-2022) & (K Units)
  • Table 46. North America Biologic Injectors Sales by Type (2023-2028) & (K Units)
  • Table 47. North America Biologic Injectors Revenue by Type (2017-2022) & (US$ Million)
  • Table 48. North America Biologic Injectors Revenue by Type (2023-2028) & (US$ Million)
  • Table 49. North America Biologic Injectors Sales by Application (2017-2022) & (K Units)
  • Table 50. North America Biologic Injectors Sales by Application (2023-2028) & (K Units)
  • Table 51. North America Biologic Injectors Revenue by Application (2017-2022) & (US$ Million)
  • Table 52. North America Biologic Injectors Revenue by Application (2023-2028) & (US$ Million)
  • Table 53. North America Biologic Injectors Sales by Country (2017-2022) & (K Units)
  • Table 54. North America Biologic Injectors Sales by Country (2023-2028) & (K Units)
  • Table 55. North America Biologic Injectors Revenue by Country (2017-2022) & (US$ Million)
  • Table 56. North America Biologic Injectors Revenue by Country (2023-2028) & (US$ Million)
  • Table 57. Europe Biologic Injectors Sales by Type (2017-2022) & (K Units)
  • Table 58. Europe Biologic Injectors Sales by Type (2023-2028) & (K Units)
  • Table 59. Europe Biologic Injectors Revenue by Type (2017-2022) & (US$ Million)
  • Table 60. Europe Biologic Injectors Revenue by Type (2023-2028) & (US$ Million)
  • Table 61. Europe Biologic Injectors Sales by Application (2017-2022) & (K Units)
  • Table 62. Europe Biologic Injectors Sales by Application (2023-2028) & (K Units)
  • Table 63. Europe Biologic Injectors Revenue by Application (2017-2022) & (US$ Million)
  • Table 64. Europe Biologic Injectors Revenue by Application (2023-2028) & (US$ Million)
  • Table 65. Europe Biologic Injectors Sales by Country (2017-2022) & (K Units)
  • Table 66. Europe Biologic Injectors Sales by Country (2023-2028) & (K Units)
  • Table 67. Europe Biologic Injectors Revenue by Country (2017-2022) & (US$ Million)
  • Table 68. Europe Biologic Injectors Revenue by Country (2023-2028) & (US$ Million)
  • Table 69. Asia Pacific Biologic Injectors Sales by Type (2017-2022) & (K Units)
  • Table 70. Asia Pacific Biologic Injectors Sales by Type (2023-2028) & (K Units)
  • Table 71. Asia Pacific Biologic Injectors Revenue by Type (2017-2022) & (US$ Million)
  • Table 72. Asia Pacific Biologic Injectors Revenue by Type (2023-2028) & (US$ Million)
  • Table 73. Asia Pacific Biologic Injectors Sales by Application (2017-2022) & (K Units)
  • Table 74. Asia Pacific Biologic Injectors Sales by Application (2023-2028) & (K Units)
  • Table 75. Asia Pacific Biologic Injectors Revenue by Application (2017-2022) & (US$ Million)
  • Table 76. Asia Pacific Biologic Injectors Revenue by Application (2023-2028) & (US$ Million)
  • Table 77. Asia Pacific Biologic Injectors Sales by Region (2017-2022) & (K Units)
  • Table 78. Asia Pacific Biologic Injectors Sales by Region (2023-2028) & (K Units)
  • Table 79. Asia Pacific Biologic Injectors Revenue by Region (2017-2022) & (US$ Million)
  • Table 80. Asia Pacific Biologic Injectors Revenue by Region (2023-2028) & (US$ Million)
  • Table 81. Latin America Biologic Injectors Sales by Type (2017-2022) & (K Units)
  • Table 82. Latin America Biologic Injectors Sales by Type (2023-2028) & (K Units)
  • Table 83. Latin America Biologic Injectors Revenue by Type (2017-2022) & (US$ Million)
  • Table 84. Latin America Biologic Injectors Revenue by Type (2023-2028) & (US$ Million)
  • Table 85. Latin America Biologic Injectors Sales by Application (2017-2022) & (K Units)
  • Table 86. Latin America Biologic Injectors Sales by Application (2023-2028) & (K Units)
  • Table 87. Latin America Biologic Injectors Revenue by Application (2017-2022) & (US$ Million)
  • Table 88. Latin America Biologic Injectors Revenue by Application (2023-2028) & (US$ Million)
  • Table 89. Latin America Biologic Injectors Sales by Country (2017-2022) & (K Units)
  • Table 90. Latin America Biologic Injectors Sales by Country (2023-2028) & (K Units)
  • Table 91. Latin America Biologic Injectors Revenue by Country (2017-2022) & (US$ Million)
  • Table 92. Latin America Biologic Injectors Revenue by Country (2023-2028) & (US$ Million)
  • Table 93. Middle East and Africa Biologic Injectors Sales by Type (2017-2022) & (K Units)
  • Table 94. Middle East and Africa Biologic Injectors Sales by Type (2023-2028) & (K Units)
  • Table 95. Middle East and Africa Biologic Injectors Revenue by Type (2017-2022) & (US$ Million)
  • Table 96. Middle East and Africa Biologic Injectors Revenue by Type (2023-2028) & (US$ Million)
  • Table 97. Middle East and Africa Biologic Injectors Sales by Application (2017-2022) & (K Units)
  • Table 98. Middle East and Africa Biologic Injectors Sales by Application (2023-2028) & (K Units)
  • Table 99. Middle East and Africa Biologic Injectors Revenue by Application (2017-2022) & (US$ Million)
  • Table 100. Middle East and Africa Biologic Injectors Revenue by Application (2023-2028) & (US$ Million)
  • Table 101. Middle East and Africa Biologic Injectors Sales by Country (2017-2022) & (K Units)
  • Table 102. Middle East and Africa Biologic Injectors Sales by Country (2023-2028) & (K Units)
  • Table 103. Middle East and Africa Biologic Injectors Revenue by Country (2017-2022) & (US$ Million)
  • Table 104. Middle East and Africa Biologic Injectors Revenue by Country (2023-2028) & (US$ Million)
  • Table 105. BD Corporation Information
  • Table 106. BD Description and Major Businesses
  • Table 107. BD Biologic Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 108. BD Biologic Injectors Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 109. BD Recent Developments
  • Table 110. Johnson & Johnson Corporation Information
  • Table 111. Johnson & Johnson Description and Major Businesses
  • Table 112. Johnson & Johnson Biologic Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 113. Johnson & Johnson Biologic Injectors Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 114. Johnson & Johnson Recent Developments
  • Table 115. Roche Corporation Information
  • Table 116. Roche Description and Major Businesses
  • Table 117. Roche Biologic Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 118. Roche Biologic Injectors Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 119. Roche Recent Developments
  • Table 120. Schott Corporation Information
  • Table 121. Schott Description and Major Businesses
  • Table 122. Schott Biologic Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 123. Schott Biologic Injectors Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 124. Schott Recent Developments
  • Table 125. Bayer Corporation Information
  • Table 126. Bayer Description and Major Businesses
  • Table 127. Bayer Biologic Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 128. Bayer Biologic Injectors Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 129. Bayer Recent Developments
  • Table 130. Nipro Corporation Information
  • Table 131. Nipro Description and Major Businesses
  • Table 132. Nipro Biologic Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 133. Nipro Biologic Injectors Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 134. Nipro Recent Developments
  • Table 135. Ompi Corporation Information
  • Table 136. Ompi Description and Major Businesses
  • Table 137. Ompi Biologic Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 138. Ompi Biologic Injectors Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 139. Ompi Recent Developments
  • Table 140. Novartis Corporation Information
  • Table 141. Novartis Description and Major Businesses
  • Table 142. Novartis Biologic Injectors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
  • Table 143. Novartis Biologic Injectors Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 144. Novartis Recent Developments
  • Table 145. Key Raw Materials Lists
  • Table 146. Raw Materials Key Suppliers Lists
  • Table 147. Biologic Injectors Distributors List
  • Table 148. Biologic Injectors Customers List
  • Table 149. Biologic Injectors Market Trends
  • Table 150. Biologic Injectors Market Drivers
  • Table 151. Biologic Injectors Market Challenges
  • Table 152. Biologic Injectors Market Restraints
  • Table 153. Research Programs/Design for This Report
  • Table 154. Key Data Information from Secondary Sources
  • Table 155. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Biologic Injectors Product Picture
  • Figure 3. Global Biologic Injectors Market Share by Type in 2021 & 2028
  • Figure 3. Disposable Biologic Injectors Product Picture
  • Figure 4. Reusable Biologic Injectors Product Picture
  • Figure 5. Global Biologic Injectors Market Share by Application in 2021 & 2028
  • Figure 6. Hospitals
  • Figure 7. Clinics
  • Figure 8. Ambulatory Surgical Centers
  • Figure 9. Others
  • Figure 10. Biologic Injectors Report Years Considered
  • Figure 11. Global Biologic Injectors Sales 2017-2028 (K Units)
  • Figure 12. Global Biologic Injectors Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 13. Global Biologic Injectors Revenue 2017-2028 (US$ Million)
  • Figure 14. Global Biologic Injectors Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 15. Global Biologic Injectors Sales Market Share by Region (2017-2022)
  • Figure 16. Global Biologic Injectors Sales Market Share by Region (2023-2028)
  • Figure 17. North America Biologic Injectors Sales YoY (2017-2028) & (K Units)
  • Figure 18. North America Biologic Injectors Revenue YoY (2017-2028) & (US$ Million)
  • Figure 19. Europe Biologic Injectors Sales YoY (2017-2028) & (K Units)
  • Figure 20. Europe Biologic Injectors Revenue YoY (2017-2028) & (US$ Million)
  • Figure 21. Asia-Pacific Biologic Injectors Sales YoY (2017-2028) & (K Units)
  • Figure 22. Asia-Pacific Biologic Injectors Revenue YoY (2017-2028) & (US$ Million)
  • Figure 23. Latin America Biologic Injectors Sales YoY (2017-2028) & (K Units)
  • Figure 24. Latin America Biologic Injectors Revenue YoY (2017-2028) & (US$ Million)
  • Figure 25. Middle East & Africa Biologic Injectors Sales YoY (2017-2028) & (K Units)
  • Figure 26. Middle East & Africa Biologic Injectors Revenue YoY (2017-2028) & (US$ Million)
  • Figure 27. The Biologic Injectors Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 28. The Top 5 and 10 Largest Manufacturers of Biologic Injectors in the World: Market Share by Biologic Injectors Revenue in 2021
  • Figure 29. Global Biologic Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 30. Global Biologic Injectors Sales Market Share by Type (2017-2028)
  • Figure 31. Global Biologic Injectors Revenue Market Share by Type (2017-2028)
  • Figure 32. Global Biologic Injectors Sales Market Share by Application (2017-2028)
  • Figure 33. Global Biologic Injectors Revenue Market Share by Application (2017-2028)
  • Figure 34. North America Biologic Injectors Sales Market Share by Type (2017-2028)
  • Figure 35. North America Biologic Injectors Revenue Market Share by Type (2017-2028)
  • Figure 36. North America Biologic Injectors Sales Market Share by Application (2017-2028)
  • Figure 37. North America Biologic Injectors Revenue Market Share by Application (2017-2028)
  • Figure 38. North America Biologic Injectors Sales Share by Country (2017-2028)
  • Figure 39. North America Biologic Injectors Revenue Share by Country (2017-2028)
  • Figure 40. U.S. Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 41. Canada Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 42. Europe Biologic Injectors Sales Market Share by Type (2017-2028)
  • Figure 43. Europe Biologic Injectors Revenue Market Share by Type (2017-2028)
  • Figure 44. Europe Biologic Injectors Sales Market Share by Application (2017-2028)
  • Figure 45. Europe Biologic Injectors Revenue Market Share by Application (2017-2028)
  • Figure 46. Europe Biologic Injectors Sales Share by Country (2017-2028)
  • Figure 47. Europe Biologic Injectors Revenue Share by Country (2017-2028)
  • Figure 48. Germany Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 49. France Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 50. U.K. Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 51. Italy Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 52. Russia Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 53. Asia Pacific Biologic Injectors Sales Market Share by Type (2017-2028)
  • Figure 54. Asia Pacific Biologic Injectors Revenue Market Share by Type (2017-2028)
  • Figure 55. Asia Pacific Biologic Injectors Sales Market Share by Application (2017-2028)
  • Figure 56. Asia Pacific Biologic Injectors Revenue Market Share by Application (2017-2028)
  • Figure 57. Asia Pacific Biologic Injectors Sales Share by Region (2017-2028)
  • Figure 58. Asia Pacific Biologic Injectors Revenue Share by Region (2017-2028)
  • Figure 59. China Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 60. Japan Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 61. South Korea Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 62. India Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 63. Australia Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 64. Taiwan Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 65. Indonesia Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 66. Thailand Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 67. Malaysia Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 68. Philippines Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 69. Latin America Biologic Injectors Sales Market Share by Type (2017-2028)
  • Figure 70. Latin America Biologic Injectors Revenue Market Share by Type (2017-2028)
  • Figure 71. Latin America Biologic Injectors Sales Market Share by Application (2017-2028)
  • Figure 72. Latin America Biologic Injectors Revenue Market Share by Application (2017-2028)
  • Figure 73. Latin America Biologic Injectors Sales Share by Country (2017-2028)
  • Figure 74. Latin America Biologic Injectors Revenue Share by Country (2017-2028)
  • Figure 75. Mexico Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 76. Brazil Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 77. Argentina Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 78. Middle East and Africa Biologic Injectors Sales Market Share by Type (2017-2028)
  • Figure 79. Middle East and Africa Biologic Injectors Revenue Market Share by Type (2017-2028)
  • Figure 80. Middle East and Africa Biologic Injectors Sales Market Share by Application (2017-2028)
  • Figure 81. Middle East and Africa Biologic Injectors Revenue Market Share by Application (2017-2028)
  • Figure 82. Middle East and Africa Biologic Injectors Sales Share by Country (2017-2028)
  • Figure 83. Middle East and Africa Biologic Injectors Revenue Share by Country (2017-2028)
  • Figure 84. Turkey Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 85. Saudi Arabia Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 86. UAE Biologic Injectors Revenue (2017-2028) & (US$ Million)
  • Figure 87. Biologic Injectors Value Chain
  • Figure 88. Biologic Injectors Production Process
  • Figure 89. Channels of Distribution
  • Figure 90. Distributors Profiles
  • Figure 91. Bottom-up and Top-down Approaches for This Report
  • Figure 92. Data Triangulation
  • Figure 93. Key Executives Interviewed